This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_DLBCL_EXALLC for full statistics.
Diffuse large B-cell lymphoma
C3_DLBCL
diffuse large B-cell lymphoma: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL; see this term) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
1538 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1538 |
4. Check minimum number of eventsNone |
1538 |
5. Include endpoints |
1538 |
6. Filter based on genotype QC (FinnGen only) |
1538 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Diffuse large B-cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Diffuse large B-cell lymphoma, helper endpoint
- Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1538 | 679 | 859 |
| Unadjusted period prevalence (%) | 0.31 | 0.23 | 0.38 |
| Median age at first event (years) | 67.90 | 66.78 | 68.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1413
- Matched controls
- 14130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L03AA13
ATC
pegfilgrastim; parenteral
44.1
323.0
555
204
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
74.2
323.0
412
78
A03FA01
ATC
metoclopramide; systemic, rectal
12.3
323.0
915
1837
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
12695.5
323.0
1308
16
L03AA02
ATC
filgrastim; parenteral
53.9
323.0
507
145
XW000
NOMESCO Finland
Bone marrow biopsy
24.4
323.0
494
304
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
333.5
323.0
1225
271
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
41.2
323.0
629
270
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
63.1
323.0
474
112
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
3939.7
323.0
321
*
M04AA01
ATC
allopurinol; systemic
11.7
323.0
769
1306
JN4BD
NOMESCO Finland
Extensive body CT
12.0
320.4
689
1037
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
443.4
289.7
281
8
WW500
NOMESCO Finland
Blood transfusion
21.3
249.4
383
242
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
234.0
218
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
113.8
221.2
237
25
A04AA01
ATC
ondansetron; systemic, rectal
11.8
213.6
430
504
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
108.3
196.6
212
23
H02AB06
ATC
prednisolone; systemic
5.8
192.8
1074
4992
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
22.4
189.8
284
157
1XC02
NOMESCO Finland
NA
78.4
185.1
208
31
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
37.9
182.9
235
74
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.0
170.8
352
414
D70.82
ICD-10 Finland
Drug-induced neutropenia
35.0
168.1
220
74
ZX120
NOMESCO Finland
Intravenous
7.9
165.0
424
723
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
122.2
161.2
172
16
JN6AD
NOMESCO Finland
CT of torso and neck
37.2
156.7
202
63
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
38.4
155.5
199
60
JN4AD
NOMESCO Finland
Body CT examination
8.0
155.0
391
641
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.6
151.6
454
948
A04AA02
ATC
granisetron; systemic, transdermal
9.9
151.6
330
422
L03AA14
ATC
lipegfilgrastim; parenteral
25.8
143.0
203
91
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
190.9
134.1
138
8
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
35.2
122.7
160
51
N02AA05
ATC
oxycodone; systemic
4.7
117.7
485
1406
PJA10
NOMESCO Finland
Exploration of lymph nodes
34.6
116.1
152
49
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
10.5
113.7
234
261
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
176.9
110.0
114
7
A02BC02
ATC
pantoprazole; systemic
4.2
109.2
1164
7470
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
39.5
107.2
136
38
R50.9
ICD-10 Finland
Fever, unspecified
4.6
99.7
408
1144
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
18.0
99.1
158
98
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
98.0
697
3138
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.9
97.0
149
83
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
22.2
93.9
139
69
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.7
93.0
232
352
WF003
NOMESCO Finland
Adjuvant radiotherapy
9.4
83.2
181
218
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
77.8
876
5101
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.8
73
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.5
75.5
153
161
XX9CD
NOMESCO Finland
Very extensive complementary CT
381.4
73.4
73
*
H02AB07
ATC
prednisone; oral
3.8
73.1
371
1222
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.5
68
*
ZX112
NOMESCO Finland
Subcutaneous
11.2
70.6
138
135
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
26.6
69.6
97
39
J05AB11
ATC
valaciclovir; oral
4.0
69.1
323
985
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
67.4
345
1135
WW300
NOMESCO Finland
Transfer of autologic stem cells
66.8
66.1
76
12
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
64.0
61
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
15.1
63.2
107
76
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
12.3
62.4
116
102
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.3
61.4
114
100
212
Kela drug reimbursment
Gout
9.4
60.6
130
151
L01CB01
ATC
etoposide; systemic
41.6
60.1
75
19
H02AB02
ATC
dexamethasone; systemic
3.9
59.3
277
834
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.2
59.2
151
231
XX3DW
NOMESCO Finland
Time consuming IT work
3.8
58.2
277
846
B72
ICPC
Hodgkin Lymphoma
569.7
56.0
55
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
281.4
53.5
54
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
16.2
53.1
87
57
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
52.7
187
429
Z51.5
ICD-10 Finland
Palliative care
4.6
52.3
199
491
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.4
50.7
200
510
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
50.3
48
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
50.3
48
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
22.6
50.1
73
34
WF002
NOMESCO Finland
Radical radiotherapy
4.9
49.3
173
391
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
48.5
175
407
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
48.2
46
*
TAB00
NOMESCO Finland
Lumbar puncture
6.5
47.8
131
220
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
129.5
47.1
50
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.4
45.5
247
824
J01MA12
ATC
levofloxacin; systemic
2.6
45.2
395
1811
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
16.8
44.7
72
45
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
46.7
44.4
54
12
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
24.0
43.5
62
27
WZC30
NOMESCO Finland
Teaching
3.0
43.4
294
1145
B01AB05
ATC
enoxaparin; parenteral
2.3
43.0
568
3214
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
39.8
38
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
39.1
440
2277
C83.1
ICD-10 Finland
Mantle cell lymphoma
38.2
38.0
48
13
A41.9
ICD-10 Finland
Sepsis, unspecified
5.3
37.9
121
245
B01AB10
ATC
tinzaparin; parenteral
3.7
37.7
179
534
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.5
37.4
115
223
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
36.3
144
366
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
35.7
242
932
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.6
35.6
70
69
N02BE01
ATC
paracetamol; systemic, rectal
2.6
35.4
1251
10532
WW409
NOMESCO Finland
Other aferesis
60.2
35.3
41
7
ZX070
NOMESCO Finland
Intensity modified radiotherapy
7.0
35.1
89
134
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.9
34.0
98
175
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
33.5
122
284
JN4CD
NOMESCO Finland
Very extensive body CT
4.4
32.6
123
297
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.4
31
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
32.4
314
1487
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
32.3
387
2032
D69.5
ICD-10 Finland
Secondary thrombocytopenia
44.5
31.9
39
9
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.7
31.9
149
437
WF004
NOMESCO Finland
Palliative radiotherapy
6.7
31.8
83
130
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.1
31.4
60
56
TGC00
NOMESCO Finland
Bronchial lavation
5.4
30.6
95
186
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
15.7
30.5
50
33
C83.00
ICD-10 Finland
Lymphocytic lymphoma
28.1
30.3
41
15
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
30.2
463
2690
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.8
29.8
61
65
J05AB01
ATC
aciclovir; systemic
2.3
29.5
336
1711
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
37.9
29.4
37
10
FM1FN
NOMESCO Finland
Heart function isotope examination
22.7
29.3
42
19
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.6
28.7
139
419
H02AB09
ATC
hydrocortisone; systemic
6.8
28.5
73
112
C03CA01
ATC
furosemide; systemic
2.0
28.2
522
3250
TPX15
NOMESCO Finland
Removal of vascular injection port
21.6
27.5
40
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.2
27.3
87
176
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
26.9
86
174
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
26.9
343
1829
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
26.6
417
2420
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
34.8
26.6
34
10
A07AA02
ATC
nystatin; oral
3.2
26.2
146
487
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
21.7
26.1
38
18
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
26.1
25
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
40.9
25.9
32
8
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
19.1
25.7
39
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
25.5
210
899
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
16.2
25.5
41
26
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
26.7
24.9
34
13
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.6
24.9
38
21
YNB10
NOMESCO Finland
Collection of stem cells for transplant
91.7
24.7
27
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.9
24.4
56
73
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
49.3
24.3
29
6
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.3
24.0
45
41
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
19.9
23.5
35
18
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
23.3
465
2926
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
28.8
23.2
31
11
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
22.5
23.1
33
15
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
23.0
22
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
10.3
22.9
45
45
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.4
22.9
86
207
KFC00
NOMESCO Finland
Unilateral orchiectomy
13.9
22.3
38
28
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.9
22.2
63
111
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
21.8
73
156
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
21.8
167
683
ZX108
NOMESCO Finland
Inhalation
13.0
21.7
38
30
AAA10
NOMESCO Finland
Biopsy through craniotomy
223.3
21.7
22
*
Z2446
NOMESCO Finland
Social worker
3.1
20.6
119
408
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
42.3
20.5
25
6
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.4
20.5
54
87
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
20.3
153
621
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
20.3
199
929
E83.50
ICD-10 Finland
Hypercalcemia
7.7
20.2
47
63
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
13.3
20.2
35
27
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.1
20.2
64
129
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
19.8
19
*
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
74.6
19.7
22
*
ZX131
NOMESCO Finland
Intrathecal
106.5
19.6
21
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
19.7
19.5
29
15
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
26.4
19.2
26
10
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
19.0
74
185
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
15.1
19.0
31
21
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
18.8
18
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
12.5
18.6
33
27
3AA13
NOMESCO Finland
NA
38.9
18.6
23
6
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
192.4
18.6
19
*
J01MA14
ATC
moxifloxacin; systemic
2.4
18.4
161
705
ZXD05
NOMESCO Finland
Urgent procedure
1.7
18.4
450
2982
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
18.2
187
890
B02.9
ICD-10 Finland
Zoster without complication
2.9
17.9
112
404
WX882
NOMESCO Finland
High dependency care
4.2
17.8
69
172
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
5.0
17.7
57
118
WW200
NOMESCO Finland
Immunization
4.2
17.3
67
167
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.5
17.2
33
32
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
16.2
17.0
27
17
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.0
17.0
55
114
WX110
NOMESCO Finland
Local anesthesy
1.6
17.0
903
7351
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
19.5
16.9
25
13
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
EMA10
NOMESCO Finland
Biopsy of tonsil
27.9
16.5
22
8
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
16.2
61
148
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.4
16.2
33
36
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
24.8
16.0
22
9
JFB00
NOMESCO Finland
Partial resection of small intestine
5.4
16.0
48
92
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.7
15.9
40
61
KA1FN
NOMESCO Finland
Isotope renography
8.1
15.8
35
44
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
15.8
663
5037
WX002
NOMESCO Finland
Sedation and analgesia
1.8
15.8
315
1941
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
33.8
15.8
20
6
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
A79
ICPC
Malignancy NOS
5.5
15.6
46
86
J01DB01
ATC
cefalexin; oral
1.7
15.5
1095
9487
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
161.7
15.5
16
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
161.7
15.5
16
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
15.3
484
3406
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
15.2
88
303
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
14.9
538
3918
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.5
14.7
34
46
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
14.6
14
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
14.6
14
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
14.6
14
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
151.5
14.5
15
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
15.6
14.4
23
15
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.7
14.4
48
104
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.3
14.3
31
38
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
13.5
14.2
24
18
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
8.1
14.1
31
39
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
14.1
148
709
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
11.0
14.0
26
24
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
30.4
13.9
18
6
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
75.9
13.6
15
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.1
13.6
42
84
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
13.6
13
*
WW402
NOMESCO Finland
Leucoferesis
34.4
13.5
17
5
1BC01
NOMESCO Finland
NA
141.3
13.5
14
*
127
Kela drug reimbursment
Transplant complication
5.1
13.4
42
85
1CX01
NOMESCO Finland
NA
26.0
13.4
18
7
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
13.3
152
755
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
7.6
13.2
30
40
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.6
13.1
45
101
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
22.8
12.9
18
8
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.6
12.9
58
167
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
12.7
62
190
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
10.2
12.5
24
24
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.0
445
3219
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
5.4
12.0
35
66
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
11.9
250
1548
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
6.5
11.9
30
47
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
23.1
11.6
16
7
TGD00
NOMESCO Finland
Needle biopsy of lung
9.3
11.5
23
25
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
11.5
11
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.5
11
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
11.4
66
229
A06AD11
ATC
lactulose; oral
1.8
11.3
224
1362
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.1
11.2
61
203
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
20.2
11.1
16
8
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
20.2
11.1
16
8
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.5
10.9
31
57
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
6.2
10.8
28
46
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
21.6
10.7
15
7
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
10.5
123
617
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
3.9
10.3
41
107
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
6.1
10.3
27
45
Z52.89
ICD-10 Finland
Donor of other organ or tissue
23.5
10.2
14
6
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.1
10.2
31
62
N05CF01
ATC
zopiclone; oral
1.5
10.2
451
3368
R4110
NOMESCO Finland
Physiotherapy
1.5
10.1
367
2625
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.0
356
2529
ZXE00
NOMESCO Finland
One hour or less
1.5
10.0
531
4119
L01AA02
ATC
chlorambucil; oral
16.8
9.9
15
9
A07AA09
ATC
vancomycin; oral
4.7
9.8
32
69
R11
ICD-10 Finland
Nausea and vomiting
2.1
9.8
111
550
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
9.7
217
1366
Z3231
NOMESCO Finland
Registered nurse
1.5
9.7
374
2706
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
9.6
108
534
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
9.6
96
451
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
15.1
9.5
15
10
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
100.7
9.4
10
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
17.7
9.4
14
8
WX892
NOMESCO Finland
Monitored bed care
2.0
9.4
119
617
1DB01
NOMESCO Finland
NA
+∞
9.4
9
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
9.4
573
4554
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.0
9.3
22
32
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.0
9.3
53
181
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
5.3
9.2
27
52
Z2221
NOMESCO Finland
Medical doctor
1.5
9.2
357
2583
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.4
9.1
26
49
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
11.5
9.1
16
14
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
9.0
48
159
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.1
9.0
17
17
R4190
NOMESCO Finland
Nutritional therapy
2.8
8.9
54
195
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
24.2
8.9
12
5
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
24.2
8.9
12
5
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.2
8.9
32
77
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.9
8.8
21
31
Z51.0
ICD-10 Finland
Radiotherapy session
4.4
8.7
30
69
Z94.1
ICD-10 Finland
Heart transplant status
14.1
8.7
14
10
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
14.1
8.7
14
10
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
50.3
8.7
10
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.6
8.7
21
32
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
27.7
8.5
11
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.7
8.4
27
58
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.7
8.4
20
30
N03AX16
ATC
pregabalin; oral
1.5
8.3
316
2266
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.3
8
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
ZXA00
NOMESCO Finland
Right side
1.5
8.3
387
2899
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
10.8
8.3
15
14
ENA10
NOMESCO Finland
Biopsy of pharynx
9.5
8.3
16
17
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.1
257
1768
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
33.5
8.1
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.1
8.1
42
138
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
17.3
8.1
12
7
JN4DD
NOMESCO Finland
Scout CT scan of torso
17.3
8.1
12
7
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
7.9
38
118
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.7
7.8
21
37
R06AE07
ATC
cetirizine; oral
1.4
7.7
496
3939
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
15.1
7.7
12
8
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
15.1
7.7
12
8
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.6
7.7
33
94
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.9
7.6
45
161
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.5
7.6
33
95
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
8.1
7.6
16
20
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
11.9
7.6
13
11
EMB10
NOMESCO Finland
Tonsillectomy
3.0
7.5
43
148
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
7.5
101
541
TK800
NOMESCO Finland
Hemodialysis
3.1
7.4
38
124
JAH21
NOMESCO Finland
Staging laparoscopy
80.5
7.4
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
3.3
7.4
35
108
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
7.4
243
1687
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
10.9
7.3
13
12
B02
ICPC
Lymph gland(s) enlarged/painful
6.9
7.3
17
25
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
7.3
7
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
7.3
89
458
N03AX14
ATC
levetiracetam; systemic
2.8
7.3
44
161
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
5.2
7.3
21
41
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.1
7.2
78
382
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
15.8
7.2
11
7
B74
ICPC
Malignant neoplasm blood other
15.8
7.2
11
7
Z51.88
ICD-10 Finland
Other specified medical care
3.5
7.2
32
94
WX720
NOMESCO Finland
Own respiration
2.4
7.2
57
242
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
7.2
325
2415
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
30.2
7.2
9
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
12.1
7.1
12
10
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
7.0
89
466
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
7.0
85
438
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
7.0
66
303
JAH01
NOMESCO Finland
Laparoscopy
2.4
7.0
58
251
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.0
479
3833
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.2
6.9
20
39
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
13.8
6.9
11
8
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.6
6.9
48
189
C07AB07
ATC
bisoprolol; oral
1.3
6.8
672
5690
A41.8
ICD-10 Finland
Other specified sepsis
3.1
6.8
34
110
C85.0
ICD-10 Finland
Lymphosarcoma
40.2
6.8
8
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
40.2
6.8
8
*
OAA41
NOMESCO Finland
Health check based on individual needs
40.2
6.8
8
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.5
6.7
29
84
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.0
6.7
35
117
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
22.6
6.7
9
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.8
6.7
40
146
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
6.6
59
265
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
6.5
6.6
16
25
UJF32
NOMESCO Finland
Coloscopy
1.4
6.6
349
2663
GEA00
NOMESCO Finland
Mediastinoscopy
5.9
6.6
17
29
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.9
6.6
25
65
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
12.3
6.6
11
9
C09AA05
ATC
ramipril; oral
1.4
6.6
364
2800
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.8
6.5
20
42
R50.8
ICD-10 Finland
Other specified fever
6.9
6.5
15
22
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
6.5
75
379
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
6.5
63
295
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
5.3
6.5
18
34
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.3
6.4
22
52
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
70.2
6.4
7
*
A06AH03
ATC
naloxegol; oral
4.1
6.4
23
57
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
14.4
6.4
10
7
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
6.3
69
339
WX402
NOMESCO Finland
General anaesthesia
1.5
6.3
198
1353
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.3
246
1769
CKA10
NOMESCO Finland
Biopsy of vitreous body
11.1
6.3
11
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.3
236
1680
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
18.1
6.3
9
5
J01CA04
ATC
amoxicillin; systemic
1.4
6.3
992
8980
1CA02
NOMESCO Finland
NA
+∞
6.3
6
*
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
6.3
6
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
6.3
6
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.3
425
3381
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
26.8
6.2
8
*
1AA09
NOMESCO Finland
NA
26.8
6.2
8
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
26.8
6.2
8
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
26.8
6.2
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.2
151
970
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.8
6.2
93
519
RS220
NOMESCO Finland
NA
3.8
6.2
24
64
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.3
6.2
15
24
WX199
NOMESCO Finland
Other local analgesia
2.5
6.1
44
178
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.7
6.1
13
17
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
12.6
6.1
10
8
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.4
6.1
27
81
SPAT1153
SPAT
Removal of sutures
1.4
6.0
436
3501
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
10.1
6.0
11
11
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
10.1
6.0
11
11
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.7
6.0
39
148
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3045142) Bone marrow Pathology biopsy report
341
160
27.10
307.65
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
812
1318
11.93
307.65
1.5
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
289
97
36.46
307.65
2.4
1.8
e9/l
1.0
1.1
0.39
206
54
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
236
67
41.43
307.65
2.2
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
689
655
18.24
307.65
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
764
1053
13.43
307.65
1.5
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1079
1674
19.25
307.65
8.1
4.1
u/l
304.4
246.2
6.49
1049
1581
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
774
1110
13.02
307.65
1.5
1.5
—
—
—
0
0
(4035726)
645
1173
8.75
307.65
1.7
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
343
83
52.90
307.65
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
342
265
16.31
307.65
1.6
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
368
106
45.32
307.65
1.4
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
238
72
38.92
307.65
2.2
1.8
%
74.2
70.8
0.79
226
66
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
237
71
39.28
307.65
2.1
1.7
%
14.8
14.7
0.03
102
32
(3005719) IgG [Mass/volume] in Serum or Plasma
523
941
7.91
299.60
4.2
2.9
g/l
8.3
10.9
22.60
503
852
(21494815) CD4 cells/100 lymphocytes in Specimen
205
82
28.69
298.10
2.3
1.6
%
31.2
39.1
0.69
17
11
(3026493) Urate [Moles/volume] in Serum or Plasma
1024
3550
6.64
292.39
6.7
2.9
umol/l
1003.1
6682.3
7.30
986
3020
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
261
194
16.00
286.63
3.1
2.6
u/ml
9209.4
1307.4
1.23
24
18
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
290
260
13.51
284.89
5.8
5.0
iu/ml
5579.5
1006.4
0.42
43
35
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
183
71
29.12
268.51
2.5
1.9
e6/l
496.1
670.0
0.68
153
61
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
176
70
28.26
255.80
2.5
1.9
e9/l
0.2
0.3
0.94
153
61
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
247
6
485.43
254.19
8.0
12.5
umol/l
0.4
0.5
—
239
6
(3022096) Basophils/100 leukocytes in Blood
1231
5773
6.67
227.31
10.8
5.9
%
0.7
0.7
0.02
1204
5357
(42870588) Differential panel, method unspecified - Blood
1058
4427
5.45
223.00
10.4
5.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
235
220
12.43
222.96
1.4
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1281
6295
7.19
221.55
10.2
5.6
e9/l
0.6
0.6
0.21
1190
5364
(3006315) Basophils [#/volume] in Blood
1283
6324
7.20
220.77
10.2
5.7
e9/l
0.0
0.0
10.64
1192
5399
(3019069) Monocytes/100 leukocytes in Blood
1242
5957
6.64
220.55
11.5
6.2
%
9.9
8.9
15.39
1215
5541
(3006504) Eosinophils/100 leukocytes in Blood
1236
5933
6.52
218.35
11.0
5.9
%
2.6
2.9
2.80
1209
5498
(3019198) Lymphocytes [#/volume] in Blood
1284
6426
7.04
214.11
10.4
5.8
e9/l
1.6
1.9
6.30
1204
5596
(3013115) Eosinophils [#/volume] in Blood
1292
6525
7.13
212.41
11.1
5.9
e9/l
0.2
0.2
12.68
1206
5667
(3002030) Lymphocytes/100 leukocytes in Blood
1241
6064
6.42
211.91
11.4
6.1
%
24.7
26.6
6.39
1215
5609
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
157
78
22.30
208.65
2.9
1.8
e6/l
418.8
768.9
2.84
63
33
(21494814) CD8 cells/100 lymphocytes in Specimen
126
34
40.28
205.68
2.0
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
477
1101
5.83
205.27
5.9
4.1
%
1.5
0.9
2.98
302
340
(3018010) Neutrophils/100 leukocytes in Blood
1217
5954
6.00
204.31
10.1
5.9
%
58.2
58.1
0.10
1192
5537
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
118
27
47.25
200.48
2.1
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
210
195
12.31
199.78
1.4
1.4
u/ml
115.7
140.6
0.40
54
28
(3028026) IgM [Mass/volume] in Serum or Plasma
374
749
6.28
186.17
3.4
1.8
g/l
1.2
1.6
1.45
353
673
(3006245) CD3-CD19+ cells/100 cells in Blood
116
38
32.93
178.94
2.2
2.1
%
7.9
13.2
0.81
97
31
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
114
37
33.20
176.33
2.2
2.1
%
35.3
28.1
2.18
102
32
(3013650) Neutrophils [#/volume] in Blood by Automated count
1322
7388
6.62
176.00
27.6
9.0
e9/l
3.6
4.2
24.95
1249
6428
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1273
7068
5.65
165.84
16.2
6.3
umol/l
9.9
12.1
14.48
1252
6681
(3002179) Metamyelocytes/100 leukocytes in Blood
410
988
5.29
164.94
5.6
3.9
%
1.0
0.6
1.70
202
244
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
136
84
17.66
162.96
3.6
2.6
%
33.9
38.0
0.70
63
29
(3021440) Promyelocytes/100 leukocytes in Blood
418
1038
5.16
162.07
6.0
4.1
%
0.2
0.1
3.28
275
313
(40765096) Chromosome analysis panel by Banding
115
50
24.78
160.74
1.3
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
198
232
9.65
158.86
4.6
3.9
%
1.9
1.5
0.60
167
188
(3012095) Magnesium [Moles/volume] in Serum or Plasma
647
2289
4.15
157.55
8.4
3.2
mmol/l
0.8
0.8
4.39
627
2140
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
232
340
7.86
154.71
2.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
227
327
7.97
153.64
2.4
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
532
1757
4.10
140.35
3.1
2.5
%
1.8
1.8
0.19
500
1558
(3024561) Albumin [Mass/volume] in Serum or Plasma
1116
6047
4.08
138.65
9.8
4.8
g/l
33.1
34.9
18.49
1079
5602
(3000060) B lymphocytes [#/volume] in Blood
86
24
37.90
138.55
2.1
1.8
e6/l
62.0
433.3
—
35
6
(3023520) Reticulocytes [#/volume] in Blood
447
1314
4.39
138.11
3.4
2.6
e9/l
69.3
69.8
0.09
388
1025
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
187
243
8.62
137.74
2.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
174
210
9.22
135.97
1.4
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
80
18
46.83
135.87
1.3
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
72
10
75.49
133.56
1.5
4.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
197
284
7.81
132.71
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
849
4076
3.42
122.35
9.1
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
156
196
8.74
117.73
1.3
1.2
u/ml
284.0
300.6
0.18
111
104
(3025159) Blasts/100 leukocytes in Blood
353
980
4.38
115.95
5.8
4.2
%
0.1
0.4
0.51
211
266
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
164
237
7.63
109.77
2.0
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
513
1908
3.53
109.74
8.1
5.7
mmol/l
1.0
1.0
0.02
495
1748
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
353
1019
4.20
109.57
2.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
146
197
8.08
103.62
2.2
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
113
111
10.91
102.34
1.7
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
351
1071
3.95
100.16
1.7
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1126
6925
3.34
97.88
14.2
6.9
mmol/l
1.2
1.2
4.55
938
5802
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
138
187
8.01
97.49
1.9
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
593
2560
3.14
97.24
9.7
4.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
100
90
11.81
95.98
1.4
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
124
155
8.61
93.63
2.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1052
6365
3.07
91.17
12.6
6.1
mmol/l
1.2
1.2
2.39
1012
5704
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
116
144
8.63
88.01
2.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
191
402
5.28
87.07
1.4
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
131
190
7.44
87.05
2.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
89
78
12.05
86.82
4.8
3.9
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
155
270
6.27
86.53
1.6
1.4
e6/l
18.5
39.4
0.44
136
213
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
155
270
6.27
86.53
1.7
1.5
e6/l
847.1
655.9
0.12
138
222
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
110
134
8.76
84.70
2.3
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
144
238
6.57
84.65
1.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
785
4231
2.75
81.73
4.3
2.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
360
1267
3.40
81.38
2.2
2.9
g/l
62.7
66.4
11.55
341
1148
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
134
215
6.73
81.00
2.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
63
33
19.86
80.97
3.1
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
165
326
5.55
80.56
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
211
516
4.58
80.13
2.3
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
118
167
7.57
80.04
5.0
4.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
832
4665
2.71
79.31
7.9
3.4
mmol/l
2.3
2.4
0.69
777
4007
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
994
6127
2.76
77.71
7.5
4.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
59
33
18.55
73.54
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
747
4115
2.59
71.67
9.5
4.1
ph
7.4
7.4
2.08
194
787
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
558
2686
2.69
70.45
5.4
3.1
mmol/l
2.5
2.5
3.68
537
2367
(3037692) Legionella sp identified in Specimen by Organism specific culture
64
46
14.47
70.17
1.5
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
517
2411
2.72
69.34
3.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
151
315
5.21
69.15
1.6
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
85
97
9.22
68.74
2.6
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
84
95
9.30
68.39
1.3
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
137
269
5.49
67.11
1.6
1.3
mmol/l
3.8
3.9
0.62
129
254
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1350
10175
3.67
66.47
21.4
7.7
u/l
84.5
79.6
3.50
1326
9518
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
60
44
14.15
65.00
1.8
2.8
u/ml
7156.0
44689.3
—
8
10
(3013707) Erythrocyte sedimentation rate by Westergren method
1286
9476
3.18
64.63
7.5
4.2
mm/h
17.6
13.6
11.59
1240
8672
(40758558) Short blood count panel - Blood
614
3215
2.51
63.81
22.1
6.8
—
—
—
0
0
(44790047)
101
157
6.81
62.71
1.9
1.5
—
—
—
0
0
(44790049)
101
157
6.81
62.71
1.9
1.5
—
—
—
0
0
(44790048)
101
157
6.81
62.71
1.9
1.5
—
—
—
0
0
(44806118)
101
157
6.81
62.71
1.9
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
935
5956
2.45
62.37
11.1
10.6
inr
1.2
1.3
1.90
251
1639
(3007164) IgA [Mass/volume] in Serum or Plasma
463
2162
2.63
60.69
2.9
1.5
g/l
2.0
2.6
9.39
387
1248
(3017354) Segmented neutrophils/100 leukocytes in Blood
98
153
6.77
60.58
4.2
3.7
%
57.5
56.5
0.12
63
108
(3021589) Normoblasts [#/volume] in Blood
889
5595
2.40
60.07
19.8
10.1
e9/l
0.0
0.0
0.77
771
4568
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
211
640
3.66
58.94
2.6
1.9
ug/l
3.9
2.4
0.41
192
566
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
71
79
9.37
58.46
2.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
71
79
9.37
58.46
2.3
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
95
8.25
55.73
2.2
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
598
3262
2.36
54.92
4.2
2.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
452
2186
2.51
54.17
3.0
2.1
s
29.2
30.0
2.05
439
2114
(3016018) Differential panel - Cerebral spinal fluid
82
121
7.10
53.36
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
80
117
7.16
52.48
2.5
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
373
1687
2.60
51.11
2.9
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
38
18
21.62
50.72
1.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
372
1687
2.59
50.64
2.7
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
100
190
5.56
50.59
6.2
6.1
mg/l
11.6
12.0
0.46
89
177
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
80
122
6.86
50.48
2.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
80
122
6.86
50.48
2.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
80
122
6.86
50.48
2.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
790
5032
2.17
47.86
2.5
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
52
50
10.73
47.48
1.3
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
37
20
18.93
46.63
1.5
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
585
3365
2.19
45.35
6.0
4.1
%
85.4
85.9
0.22
573
3285
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
93
185
5.29
44.68
1.3
1.3
miu/ml
175.4
189.0
0.07
13
67
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
152
446
3.67
44.22
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1084
7973
2.22
43.49
9.1
5.0
mmol/l
6.7
6.8
1.05
1057
7507
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
29
10
29.54
43.29
1.6
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
123
6.27
42.95
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
398
1993
2.35
42.77
2.1
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
109
259
4.45
42.34
7.9
3.2
%
58.5
60.0
0.43
109
259
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
142
413
3.69
41.81
1.6
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
58
77
7.79
41.37
1.4
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
51
58
9.06
41.21
2.9
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
105
248
4.47
41.09
5.6
3.0
e9/l
3.6
4.6
4.14
105
248
(3042631) Mycobacterium sp identified in Specimen
97
215
4.75
41.06
2.0
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
50
57
9.03
40.32
2.9
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
50
57
9.03
40.32
2.9
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
55
72
7.89
39.69
2.9
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
55
72
7.89
39.69
2.9
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
55
72
7.89
39.69
2.9
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
55
72
7.89
39.69
2.9
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
64
8.37
39.48
4.0
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
700
4509
2.01
38.43
4.0
3.1
ng/l
2019.5
1584.9
1.66
648
3874
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
158
535
3.18
36.51
3.4
2.7
u/ml
0.4
0.4
0.03
99
310
(3028433) Virus identified in Specimen by Culture
38
34
11.43
36.32
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
121
349
3.68
35.98
1.3
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
317
1542
2.33
35.75
2.0
4.1
ug/l
7.4
20.5
1.31
219
1291
(3031040) Bacteria [#/volume] in Urine by Automated count
1121
8659
2.09
35.30
5.9
4.8
e6/l
2061.6
2037.9
0.00
21
152
(3003694) ABO and Rh group [Type] in Blood
532
3192
2.02
34.88
1.6
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
598
2.99
34.42
1.9
2.7
g/l
3.7
3.8
0.21
128
436
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
599
2.99
34.31
1.9
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
599
2.99
34.31
1.9
2.7
g/l
7.7
7.4
0.92
127
450
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
150
516
3.11
33.69
1.7
2.9
g/l
0.7
1.5
1.96
134
443
(3019832) Treponema pallidum Ab [Presence] in Serum
138
453
3.25
33.52
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
208
858
2.65
33.36
1.8
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
137
449
3.25
33.36
1.7
2.7
g/l
0.1
0.0
0.29
131
411
(3030467) Casts [#/volume] in Urine by Automated count
606
3873
1.93
32.56
4.1
3.3
e6/l
0.5
0.5
0.09
497
2987
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
556
2.99
32.33
2.0
2.8
g/l
3.7
3.1
4.98
128
442
(3008536) Aspergillus sp Ab [Presence] in Serum
35
33
10.83
32.29
2.0
1.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
37
6
63.12
32.15
1.1
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
41
50
8.40
31.32
1.5
1.1
%
65.5
71.2
—
11
5
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
70
149
4.87
31.06
4.0
2.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
168
647
2.79
30.72
1.4
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
581
3723
1.90
30.48
4.1
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
637
4218
1.87
30.06
4.3
3.4
e6/l
47.8
89.3
1.29
530
3317
(3023410) Appearance of Cerebral spinal fluid
61
121
5.21
29.35
1.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
294
1499
2.19
29.07
4.2
2.7
umol/l
8.6
9.2
0.17
260
1321
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
151
567
2.84
28.91
1.7
2.8
g/l
8.9
10.5
4.47
138
482
(3014148) Varicella zoster virus Ab [Titer] in Serum
49
81
6.22
28.56
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
70
162
4.48
28.06
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
265
1318
2.22
27.77
9.8
7.0
mmol/l
10.1
10.6
0.45
258
1257
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
124
428
3.06
27.59
1.7
2.7
g/l
0.0
0.0
0.50
118
392
(3001964) Herpes simplex virus Ag [Presence] in Specimen
33
36
9.35
27.44
1.6
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
123
424
3.07
27.43
1.7
2.7
g/l
0.0
0.0
0.00
118
391
(3018095) Leukocytes [#/volume] in Urine
692
4798
1.80
27.37
5.0
3.9
e6/l
183.5
122.2
0.30
553
3541
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
175
737
2.55
26.68
1.5
1.8
g/l
1.8
1.5
2.19
140
640
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
131
478
2.90
26.40
1.7
2.6
g/l
34.4
37.2
4.53
122
412
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
104
333
3.28
26.23
1.8
2.0
mg/l
10.9
12.1
0.87
98
303
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
102
5.24
25.34
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
236
1162
2.22
25.20
12.5
3.8
mmol/l
1.2
1.2
1.66
230
1002
(3016650) Hepatitis A virus Ab [Presence] in Serum
69
174
4.10
24.75
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
29
31
9.52
24.46
1.8
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
450
2818
1.84
24.26
3.5
2.9
mosm/kgh2o
538.0
554.5
1.01
409
2399
(3022948) Iron [Moles/volume] in Serum or Plasma
373
2211
1.91
23.83
2.5
2.6
umol/l
11.8
12.5
1.07
346
2045
(3000093) Morphology [Interpretation] in Blood Narrative
56
125
4.61
23.48
1.1
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
613
4237
1.74
23.47
2.9
2.6
u/l
50.8
57.7
2.29
558
3871
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
337
1949
1.93
23.11
2.5
2.6
%
21.7
22.4
0.35
298
1660
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
742
5424
1.71
23.06
4.9
4.0
ng/l
51.0
57.2
0.11
643
4120
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
27
29
9.46
22.68
1.7
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
348
2050
1.90
22.51
2.5
2.5
g/l
2.1
2.3
6.95
325
1895
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
196
939
2.25
22.25
6.3
3.8
mmol/l
2.1
1.8
0.44
167
707
(3000850) Epithelial cells [#/volume] in Urine
464
2999
1.78
22.19
3.4
2.6
e6/l
3.8
4.9
2.99
426
2653
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
25
10.15
22.08
1.6
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
200
978
2.20
21.56
6.2
3.8
ph
7.4
7.4
2.21
18
124
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
136
561
2.56
21.55
1.9
3.3
u/ml
325.8
7273.9
0.80
96
479
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
201
991
2.18
21.22
6.2
3.8
kpa
5.0
5.2
1.68
191
923
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
525
3565
1.72
20.83
2.1
2.2
mg/l
3.5
3.1
2.39
450
2996
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
128
529
2.55
20.19
2.0
3.8
mg/l
32.8
83.4
1.29
98
435
(3000012) Reticulocyte production index
39
73
5.46
20.01
1.5
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
127
526
2.54
19.94
1.8
1.9
u/l
43.3
39.2
0.98
112
457
(3000494) Fungus identified in Specimen by Culture
275
1555
1.94
19.90
1.9
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
127
529
2.53
19.70
2.0
3.8
mg/l
60.1
65.1
0.11
98
433
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
98
4.70
19.45
1.3
1.8
u/l
0.9
2611.5
—
10
28
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
124
518
2.52
19.11
2.0
3.8
ratio
17.1
1.6
—
10
42
(40768806) Pleura Pathology biopsy report
61
172
3.65
18.73
1.6
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
420
2747
1.73
18.73
4.6
4.0
ng/l
721.7
372.5
0.36
370
2311
(3026008) Bacteria identified in Urine by Culture
589
4212
1.65
18.72
3.7
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1387
12432
2.18
18.66
42.9
16.4
mg/l
25.7
26.4
0.38
1308
10041
(3037467) Urinalysis macro (dipstick) panel - Urine
1073
8913
1.67
18.47
5.7
4.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
228
1242
1.98
18.30
9.0
8.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
563
3998
1.64
18.30
6.8
3.2
u/l
34.4
34.5
0.02
537
3787
(3036481) Cortisol [Moles/volume] in Serum or Plasma
217
1173
1.99
17.78
2.0
2.2
nmol/l
373.5
370.4
0.08
208
1057
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
62
185
3.45
17.50
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
246
1396
1.91
17.45
6.4
3.8
mmol/l
1.8
2.0
0.35
201
1114
(3012441) Differential panel - Pleural fluid
58
166
3.59
17.44
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
82
291
2.92
17.36
2.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
151
718
2.22
17.34
7.2
3.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
262
1525
1.87
17.17
7.4
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
409
2718
1.69
16.94
2.0
1.7
mg/l
1.9
1.4
1.09
325
2106
(3026250) Tacrolimus [Mass/volume] in Blood
29
48
6.14
16.88
30.8
32.4
ug/l
6.8
6.9
0.13
24
41
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
15
10
15.14
16.77
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
130
592
2.31
16.54
3.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
98
393
2.60
16.43
2.2
4.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
132
608
2.28
16.35
7.8
4.1
mmol/l
25.6
24.9
2.07
126
570
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
57
172
3.40
15.83
2.2
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
30
55
5.54
15.75
33.8
25.3
ug/l
106.0
124.9
0.78
25
47
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
348
2253
1.70
15.74
3.9
3.1
e6/l
1.9
2.1
0.24
220
1275
(3021447) Carbon dioxide [Partial pressure] in Venous blood
241
1403
1.85
15.69
6.6
3.8
kpa
5.7
5.8
2.12
234
1358
(3025468) Yersinia sp identified in Specimen by Organism specific culture
57
173
3.38
15.69
2.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
57
173
3.38
15.69
2.2
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
63
5.17
15.56
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
57
174
3.36
15.55
2.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
57
174
3.36
15.55
2.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
57
174
3.36
15.55
2.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
61
198
3.17
15.08
1.8
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
363
2413
1.66
14.74
3.6
2.9
e6/l
1.0
1.2
0.54
234
1428
(3009871) Measles virus Ab [Titer] in Serum
20
26
7.78
14.44
1.8
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
21
29
7.33
14.42
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
80
310
2.67
14.38
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
80
310
2.67
14.38
1.4
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
184
3.18
14.23
1.5
2.2
u/ml
3.2
27.6
0.61
57
177
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
78
307
2.62
13.60
1.5
1.6
—
—
—
0
0
(3019225) pH of Specimen
237
1432
1.77
13.54
8.5
4.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
81
327
2.56
13.42
5.4
5.2
mmol/l
2.8
2.7
0.19
66
227
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
225
1343
1.79
13.39
2.4
2.2
g/l
0.2
0.2
3.22
206
1250
(3020393) Adenovirus Ag [Presence] in Stool
13
10
13.10
13.38
1.8
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
22
35
6.36
13.30
1.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
87
366
2.46
13.22
3.8
2.4
%
87.7
88.9
0.17
87
350
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
92
3.98
12.75
1.6
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
558
4216
1.51
12.67
2.4
2.2
u/l
172.4
227.3
0.84
525
3931
(3002256) Pathology report gross observation
262
1658
1.70
12.64
1.3
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
102
3.79
12.58
1.4
1.3
g/l
0.3
0.4
1.32
25
71
(3028192) IgG subclass 2 [Mass/volume] in Serum
38
102
3.79
12.58
1.4
1.3
g/l
1.8
2.9
2.21
26
71
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
102
3.79
12.58
1.4
1.3
g/l
4.8
7.3
2.87
26
70
(3024932) HLA-DR beta [Type]
21
34
6.25
12.48
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
68
4.48
12.40
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
181
1034
1.85
12.40
9.1
4.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
17
22
7.80
12.30
1.9
1.5
—
—
—
0
0
(4062490)
38
104
3.72
12.25
1.5
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
28
61
4.66
12.14
1.3
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
20
32
6.32
12.02
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
248
1571
1.69
11.88
1.9
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
111
544
2.12
11.79
2.2
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
287
1892
1.64
11.77
9.7
6.7
mmol/l
103.9
104.2
0.49
277
1840
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
25
51
4.97
11.70
1.2
1.1
ng/l
2930.8
268.2
0.89
13
16
(3035933) Granulocytes/100 leukocytes in Blood
19
30
6.40
11.56
4.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
78
333
2.41
11.50
4.0
4.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
268
1746
1.65
11.50
10.4
7.1
mmol/l
1.3
1.1
0.32
209
1350
(3014111) Lactate [Moles/volume] in Serum or Plasma
211
1293
1.73
11.38
8.1
7.1
mmol/l
1.7
1.4
2.11
201
1247
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
73
4.17
11.35
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
73
4.17
11.35
1.7
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
204
1240
1.74
11.32
2.2
2.4
u/l
33.8
38.9
0.53
178
1052
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
266
1741
1.64
11.19
10.3
7.1
kpa
4.9
5.1
1.74
249
1664
(3027801) Oxygen [Partial pressure] in Arterial blood
266
1742
1.64
11.16
10.3
7.1
kpa
12.2
11.9
0.47
252
1668
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
30
74
4.11
11.16
1.2
1.1
mg/l
93.3
38.8
1.90
22
66
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
92
3.76
11.15
1.6
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
150
838
1.88
11.00
2.5
3.3
e9/l
3.7
4.2
1.69
107
621
(3016502) Oxygen saturation in Arterial blood
244
1575
1.65
10.82
11.0
7.4
%
96.1
95.4
1.71
233
1517
(3010421) pH of Blood
86
394
2.25
10.81
5.5
4.7
ph
7.4
7.4
5.06
80
322
(3023199) Leukocytes [#/volume] in Pleural fluid
55
204
2.76
10.81
1.7
1.4
e6/l
2165.3
1636.3
0.50
42
148
(3028308) Erythrocytes [#/volume] in Pleural fluid
51
182
2.86
10.76
1.5
1.4
e6/l
34054.4
100524.4
0.91
31
109
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
29
6.27
10.74
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
282
2.48
10.69
1.3
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
20
7.56
10.57
1.2
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
213
2.69
10.50
1.4
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
641
5132
1.43
10.17
3.0
2.8
ug/l
493.0
149.2
9.88
586
4641
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
648
5199
1.43
10.16
2.5
2.2
nmol/l
76.5
78.4
1.01
594
4546
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
355
2.26
9.98
1.6
1.6
iu/ml
0.1
16.1
0.50
19
75
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
173
2.83
9.97
1.6
1.6
g/l
0.6
0.9
1.18
35
133
(40761536) Microorganisms panel - Urine sediment
183
1118
1.72
9.94
4.9
4.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
126
690
1.90
9.82
8.5
4.3
mmol/l
24.2
24.2
0.01
116
628
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
5
26.19
9.82
2.8
2.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
223
1443
1.64
9.74
11.8
7.7
g/l
110.3
121.0
10.90
213
1387
(3023183) Ammonium ion [Moles/volume] in Plasma
70
309
2.33
9.62
1.6
2.9
umol/l
31.9
35.1
0.48
59
255
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
223
1449
1.63
9.58
1.3
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
37
119
3.16
9.37
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
27
5.98
9.13
1.1
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
160
966
1.73
9.06
12.7
6.6
mmol/l
24.8
24.5
0.40
149
899
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
12
9.23
8.98
1.1
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
206
1336
1.63
8.89
4.1
2.9
ng/l
276.2
221.7
0.97
195
1227
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
15
8.06
8.87
1.0
1.2
%
107.4
90.5
0.84
12
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
15
8.06
8.87
1.0
1.2
—
—
—
0
0
(4027681)
23
56
4.15
8.73
1.4
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
892
7689
1.38
8.60
4.4
3.2
u/l
70.5
55.0
2.54
824
7025
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
50
202
2.52
8.36
1.3
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
23
6.13
8.19
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
265
1855
1.52
8.17
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
84
428
2.02
8.10
4.5
3.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
70
333
2.15
8.08
4.0
2.6
%
233.0
202.4
1.54
65
318
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
27
5.60
8.03
1.1
1.1
mmol/l
2.3
1.6
—
10
19
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
56
3.97
7.89
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
35
4.90
7.89
1.1
1.1
miu/ml
1087.8
1550.7
0.81
17
35
(3022217) INR in Platelet poor plasma by Coagulation assay
279
1989
1.49
7.86
26.4
28.6
inr
1.4
1.4
0.04
39
258
(3002385) Erythrocyte distribution width [Ratio]
1115
10040
1.40
7.84
46.2
20.0
%
14.7
13.8
52.06
1102
9803
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
41
4.43
7.43
1.3
1.3
ug/l
1.5
138.3
1.14
11
18
(3013005) Retinol [Moles/volume] in Serum or Plasma
17
37
4.63
7.41
1.2
1.5
umol/l
2.3
1.9
1.06
17
31
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
25
73
3.46
7.41
1.1
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
64
308
2.12
7.21
1.3
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
167
1085
1.60
7.13
4.5
3.9
ng/l
85.7
95.8
0.67
140
933
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
27
86
3.18
7.00
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
27
86
3.18
7.00
1.1
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
109
636
1.77
6.97
2.8
3.3
pmol/l
4.3
4.4
0.85
95
549
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
35
4.61
6.94
1.2
1.3
—
—
—
0
0
(3013512) EKG study
518
4198
1.35
6.92
5.4
4.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
20
6.04
6.91
1.9
1.9
%
4.1
3.6
—
7
9
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
71
364
2.00
6.77
1.4
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
58
3.66
6.76
1.2
1.0
u/l
1.2
1.2
—
10
32
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
73
3.32
6.70
2.4
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
30
105
2.89
6.65
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
71
367
1.98
6.62
1.4
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1390
13161
1.58
6.56
42.3
19.4
mmol/l
139.2
139.6
8.79
1370
12807
(3023323) Follitropin [Units/volume] in Serum or Plasma
46
201
2.33
6.56
1.6
1.3
iu/l
28.5
28.4
0.01
41
167
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
258
3460
0.69
6.55
1.7
1.7
mmol/l
1.5
1.4
2.12
211
2845
(42529406) Shigella sp [Presence] in Stool by Culture
71
369
1.97
6.53
1.4
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
69
356
1.98
6.48
1.2
1.2
—
6.0
—
0
6
(3035880) pH of Pleural fluid
27
91
3.00
6.40
1.5
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
119
2.72
6.36
1.1
1.4
—
—
—
0
0
(3020891) Body temperature
103
611
1.73
6.24
6.1
4.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
15
34
4.45
6.24
1.9
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1390
13192
1.56
6.13
42.9
19.6
mmol/l
4.0
4.0
0.09
1368
12816
(3047181) Lactate [Moles/volume] in Blood
82
457
1.84
6.13
15.2
6.0
mmol/l
1.5
1.3
1.05
71
397
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
55
268
2.09
6.05
1.2
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
6
15.07
5.90
1.8
5.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
61
313
1.99
5.84
1.4
3.3
u/ml
23.9
1237.7
0.87
55
292
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1149
12293
0.74
5.80
4.4
4.7
mmol/l
4.4
4.5
3.37
1032
11182
(40767503) Oxygen content in Capillary blood by calculation
62
321
1.97
5.79
3.4
2.6
%
14.4
15.9
1.75
29
171
(3004716) Salmonella sp identified in Stool by Organism specific culture
89
518
1.76
5.78
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
138
2.50
5.72
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1138
12186
0.75
5.71
4.3
4.7
mmol/l
1.3
1.4
11.83
1011
10992
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
103
2.75
5.71
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
1020
9240
1.31
5.69
5.4
4.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
152
2.40
5.58
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
428
3466
1.33
5.52
5.3
4.2
estimate
0.0
0.0
0.50
181
1136
(3015235) Bicarbonate [Moles/volume] in Capillary blood
73
406
1.84
5.52
3.2
3.3
mmol/l
23.9
25.0
1.15
64
350
(3051651) Icteric interference index of Serum or Plasma
25
89
2.84
5.42
5.7
3.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
5
16.08
5.41
1.5
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
716
6223
1.28
5.38
6.2
5.3
estimate
0.0
0.0
0.00
200
1194
(3045788) Cell count panel - Pleural fluid
37
161
2.33
5.37
1.5
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
169
1174
1.49
5.36
6.5
3.1
kpa
4.9
4.5
0.92
162
1135
(3035350) Ketones [Presence] in Urine by Test strip
715
6225
1.28
5.26
4.7
3.9
estimate
0.0
0.0
0.00
196
1181
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
215
2.13
5.24
1.2
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
44
3.66
5.21
1.1
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
141
953
1.53
5.09
10.0
9.0
%
94.4
93.8
1.25
141
946
(3048879) Bone marrow aspiration report
16
45
3.58
5.05
1.5
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
179
2.21
5.03
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
99
2.65
4.99
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
706
0.46
4.98
1.8
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
62
339
1.86
4.97
1.4
1.5
g/l
0.2
0.2
0.25
57
323
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
122
803
1.56
4.97
16.9
9.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1258
11821
1.35
4.91
35.1
15.4
ml/min/173m2
76.3
75.6
0.61
1159
9776
(3009261) Glucose [Presence] in Urine by Test strip
719
6301
1.26
4.88
4.8
3.9
estimate
0.0
0.0
0.80
188
1150
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
35
157
2.26
4.77
3.8
3.9
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
17
52
3.29
4.75
1.3
1.4
mmol/l
3.4
3.3
0.08
17
46
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
33
3.96
4.71
1.7
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
45
225
2.03
4.69
1.1
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
34
152
2.26
4.68
4.9
3.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
127
2.39
4.66
1.1
1.2
u/l
75.8
52.4
0.51
24
92
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1191
12593
0.76
4.65
4.8
5.3
mmol/l
2.6
2.6
1.92
1053
11382
(3009542) Hematocrit [Volume Fraction] of Blood
1169
10902
1.30
4.59
36.9
17.9
%
36.5
39.1
14.94
711
6989
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
28
116
2.44
4.56
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1383
13233
1.45
4.56
25.2
11.2
u/l
26.8
25.7
1.70
1362
12696
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
52
278
1.90
4.49
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
204
1519
1.40
4.47
1.3
1.3
titre
795.5
499.6
0.74
44
336
(3008295) Osmolality of Serum or Plasma
34
156
2.21
4.42
1.4
1.3
mosm/kgh2o
271.4
277.8
0.96
27
113
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
45
231
1.98
4.38
3.9
3.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
58
326
1.81
4.30
2.6
2.2
g/l
118.7
129.0
1.77
41
248
(3021901) Oxygen saturation in Capillary blood
54
298
1.84
4.25
3.0
3.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
51
3.16
4.21
2.5
2.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
77
473
1.66
4.19
5.5
3.9
mmol/l
3.8
4.0
1.29
70
434
(3042733) HLA Ab [Presence] in Serum
12
32
3.77
4.09
5.6
4.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
413
3446
1.27
4.07
1.5
1.6
nmol/l
19.6
20.4
0.47
348
2897
(3022145) Colonoscopy Study observation
191
1430
1.38
4.05
1.3
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
104
694
1.53
4.03
4.5
3.8
%
51.1
48.6
0.51
104
683
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
44
3.20
3.78
1.1
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
58
340
1.73
3.77
19.7
6.3
mmol/l
104.4
105.4
0.58
50
304
(3039000) Anion gap in Blood
58
340
1.73
3.77
19.7
6.3
mmol/l
10.8
11.2
0.31
50
304
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
39
3.35
3.76
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
66
2.75
3.76
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1338
12809
1.34
3.69
32.5
15.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
155
2.09
3.68
1.2
1.2
u/ml
3.7
6.6
0.79
14
75
(3016750) Collection duration of Urine
22
91
2.44
3.64
2.6
2.1
min
517.8
490.5
—
9
63
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1114
11790
0.80
3.64
4.1
4.2
mmol/l
1.4
1.3
2.54
993
10545
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
56
2.88
3.63
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
40
3.27
3.63
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
93
622
1.53
3.59
13.4
4.8
%
1.6
1.6
0.22
84
582
(3019309) Folate [Moles/volume] in Red Blood Cells
350
2905
1.27
3.56
1.8
1.8
nmol/l
1233.4
1182.3
0.39
268
2162
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
17
5.32
3.51
1.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
17
5.32
3.51
1.6
1.4
—
—
—
0
0
(40758358) Immune stain study
6
6
10.03
3.50
1.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
92
618
1.52
3.49
13.8
4.8
%
0.9
0.9
0.08
84
579
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
58
2.78
3.42
5.5
6.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
113
795
1.45
3.42
9.6
9.5
mmol/l
24.1
24.4
0.46
106
749
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
10
7.02
3.36
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
54
2.80
3.26
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
18
72
2.52
3.21
3.0
3.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
128
934
1.40
3.19
2.1
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1129
11873
0.82
3.06
5.6
6.4
mmol/mol
40.7
40.6
0.05
1006
10849
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
16
5.02
3.05
5.6
5.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
161
1.94
3.00
1.2
1.2
u/ml
5.0
5.2
—
7
52
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
18
75
2.42
2.97
1.2
1.2
u/l
31.5
18.3
0.57
18
66
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
542
4792
1.20
2.95
5.1
4.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
77
519
1.51
2.92
2.9
3.0
g/l
0.9
0.2
0.61
41
207
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
53
330
1.63
2.83
2.0
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
57
362
1.60
2.81
3.0
3.2
nmol/l
1.0
0.8
0.80
40
282
(3035637) Corticotropin [Mass/volume] in Plasma
29
151
1.94
2.81
1.3
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
18
4.46
2.79
1.8
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
18
4.46
2.79
1.0
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
46
278
1.67
2.76
1.7
1.3
mmol/l
64.9
61.2
0.23
39
223
(3011325) HIV 1+2 Ab [Presence] in Serum
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
20
91
2.21
2.74
3.7
3.1
ph
7.4
7.4
—
8
32
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
140
1068
1.34
2.69
3.3
3.0
ml/min/173m2
57.3
61.9
0.55
51
456
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
55
2.56
2.62
1.3
1.4
umol/l
4.6
24.8
—
8
34
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
80
2.26
2.61
1.2
1.2
u/l
302.7
84.8
0.53
18
72
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
462
0.53
2.57
1.4
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
20
4.02
2.57
1.0
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
7
7.16
2.55
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
355
3057
1.21
2.50
1.7
1.7
pmol/l
40636524.2
22667095.6
0.18
283
2475
(3005322) IgE [Units/volume] in Serum or Plasma
91
657
1.41
2.47
1.2
1.3
u/ml
317.7
242.2
0.17
80
599
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
51
2.56
2.44
1.4
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
40
2.76
2.37
1.1
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
22
3.65
2.36
7.3
7.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
17
4.13
2.36
1.0
1.0
—
—
—
0
0
(4306422)
27
147
1.85
2.33
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
247
0.40
2.31
1.4
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
79
564
1.42
2.30
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
375
3274
1.19
2.27
4.5
3.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
9
5.57
2.21
6.2
4.3
g/mol
427.2
36.3
—
5
9
(3004775) Volume in Urine collected for unspecified duration
23
121
1.91
2.21
2.8
2.2
ml
755.2
628.0
—
10
76
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
502
0.59
2.21
1.3
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
36
2.79
2.20
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
48
2.51
2.18
3.0
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
24
3.35
2.18
1.8
1.1
—
—
—
0
0
(4010399)
71
984
0.71
2.16
1.5
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
14
4.30
2.15
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
55
2.38
2.12
1.5
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1399
13641
1.28
2.11
56.5
24.0
fl
92.2
91.6
5.97
1382
13387
(40768446) Kidney Pathology biopsy report
10
37
2.71
2.10
1.3
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
1399
13642
1.28
2.10
56.4
24.0
pg
30.5
30.4
1.42
1382
13386
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
43
2.57
2.10
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
165
1335
1.26
2.09
2.4
2.5
ug/l
13.8
7.1
0.85
131
1172
(3026361) Erythrocytes [#/volume] in Blood
1399
13643
1.28
2.09
56.7
24.1
e12/l
4.1
4.4
88.19
1365
13199
(3010813) Leukocytes [#/volume] in Blood
1399
13646
1.28
2.06
56.7
24.1
e9/l
6.4
6.8
5.23
1366
13202
(3000963) Hemoglobin [Mass/volume] in Blood
1399
13647
1.28
2.05
56.9
24.3
g/l
122.9
134.3
100.31
1381
13391
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1398
13640
1.27
2.01
56.8
24.1
e9/l
212.9
242.8
43.10
1367
13240
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
26
3.09
2.01
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
44
2.51
2.01
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
44
2.51
2.01
1.0
1.2
iu/ml
125.2
254.8
1.12
11
44
(21494755) Public health laboratory ask at order entry panel
40
605
0.65
1.95
1.2
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
33
2.74
1.93
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
48
323
1.50
1.92
1.1
1.2
titre
87.1
84.5
—
7
29
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
78
2.06
1.91
2.2
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
17
85
2.01
1.90
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
1227
0.76
1.86
1.4
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
100
1.91
1.85
1.1
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
152
1.72
1.84
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
342
3014
1.17
1.84
4.7
3.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
549
0.65
1.84
1.3
1.8
—
—
—
0
0
(1002224) Polysomnography panel
22
377
0.58
1.82
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
156
1277
1.25
1.81
2.2
2.2
ug/g
224.4
152.5
0.74
130
1006
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
138
1.75
1.80
2.5
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
153
1853
0.81
1.77
1.2
1.2
u/ml
14.6
12.5
0.14
44
656
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
8
30
2.68
1.72
1.4
1.4
titre
—
159.1
—
0
7
(3049717) Cytology report of Urine Cyto stain
86
657
1.33
1.72
2.7
2.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
13
3.85
1.71
2.2
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
48
2.30
1.70
4.0
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
195
1.60
1.69
1.6
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
48
334
1.45
1.67
1.1
1.2
—
1510.8
—
0
12
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
31
2.59
1.66
7.3
6.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
76
1.98
1.64
2.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
76
1.98
1.64
2.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
77
584
1.34
1.63
1.2
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
14
3.58
1.61
1.0
1.0
mg/g
16.1
7.7
—
5
14
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
20
3.01
1.58
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
628
5831
1.13
1.58
2.0
2.1
pmol/l
90.6
93.4
0.80
366
3035
(1761868) Lipid panel - Serum or Plasma
346
3854
0.87
1.54
3.0
3.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
8
33
2.43
1.54
2.8
3.0
ml/dl
14.0
15.0
—
8
28
(3044927) Protein electrophoresis panel - Urine
29
186
1.57
1.49
1.1
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
28
2.51
1.45
8.4
2.7
—
41.3
—
0
9
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
125
1.69
1.44
1.0
1.0
u/ml
1.5
2.2
—
8
44
(3017315) Amylase [Enzymatic activity/volume] in Urine
13
66
1.98
1.43
1.2
1.2
u/l
134.6
366.9
0.84
13
59
(4146454)
9
180
0.50
1.39
2.7
2.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
143
1199
1.21
1.37
4.4
3.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
167
1.57
1.35
2.8
2.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
54
2.04
1.33
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
18
106
1.71
1.29
1.1
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
35
2.29
1.27
7.8
6.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
119
994
1.21
1.21
2.4
2.1
nmol/l
12.3
12.9
0.33
111
859
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
38
2.11
1.18
1.1
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
79
1.78
1.17
1.6
1.6
u/l
17.1
8.2
—
8
43
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
36
257
1.41
1.16
2.0
1.8
iu/l
7.8
4.6
—
10
83
(4268621)
18
110
1.64
1.15
2.3
2.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
87
1.73
1.15
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
966
9295
1.11
1.13
3.9
3.8
pmol/l
15.0
15.0
0.13
873
8278
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
51
1.97
1.11
5.5
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
51
1.97
1.11
5.5
2.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
502
0.73
1.10
1.1
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
17
104
1.64
1.09
1.5
1.2
mmol/l
23.5
34.2
2.46
17
95
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
200
1766
1.15
1.08
14.4
7.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
668
6325
1.10
1.07
2.8
2.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
59
1.87
1.07
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
59
1.87
1.07
1.1
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
46
1.96
1.03
1.1
2.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
22
2.28
1.03
1.6
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
34
2.06
1.03
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
83
1.69
1.01
2.2
2.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
91
1.65
1.00
2.7
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
48
1.88
1.00
1.0
2.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
35
2.00
1.00
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
123
1.55
0.99
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
206
1.42
0.99
3.0
2.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
61
1.81
0.98
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
84
1.67
0.98
2.0
2.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
29
0.00
0.97
0.0
2.2
—
2.7
—
0
11
(3020682) Albumin/Creatinine [Ratio] in Urine
426
4568
0.91
0.97
4.0
4.0
mg/mmol
7.9
9.0
0.35
279
2889
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
211
0.61
0.97
1.4
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
141
1.50
0.95
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
171
0.58
0.91
1.3
2.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
29
2.07
0.89
1.2
2.0
mmol/l
1.2
1.2
—
6
29
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
1234
0.85
0.89
1.5
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
31
1.94
0.84
1.2
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
196
1.38
0.84
1.9
2.4
mg/l
27.0
24.7
—
8
45
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
302
2789
1.10
0.81
5.1
4.3
kg/l
1.0
1.0
1.00
51
414
(40768800) Prostate Pathology biopsy report
28
374
0.74
0.80
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
50
402
1.25
0.79
4.4
5.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
66
1.67
0.78
1.7
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
26
0.00
0.78
0.0
6.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
187
0.64
0.78
1.3
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
74
1.63
0.78
11.8
13.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
140
1.43
0.77
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
68
568
1.21
0.76
1.8
1.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
59
1.70
0.76
1.0
1.4
ug/l
5.9
8.9
—
10
51
(3002523) Influenza virus A Ag [Presence] in Specimen
18
124
1.46
0.75
1.3
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
38
1.85
0.73
2.4
1.3
ug/l
12.8
9.6
—
7
38
(3014891) Appearance of Pleural fluid
5
25
2.00
0.72
1.6
1.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
106
0.56
0.72
1.5
2.1
ug/l
1.5
1.9
—
6
89
(3026470) Cobalt [Mass/volume] in Blood
6
108
0.55
0.72
1.5
2.0
ug/l
1.7
3.1
—
6
95
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
206
0.68
0.71
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
41
327
1.26
0.71
4.2
3.4
mmol/l
7.1
7.8
0.95
41
319
(3024928) Oxygen saturation in Venous blood
41
328
1.26
0.69
9.5
3.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
395
0.78
0.66
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
585
5602
1.07
0.66
4.6
5.3
ug/l
3.3
2.9
0.17
515
4973
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
738
1.16
0.64
2.4
2.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
79
1.52
0.62
1.4
1.8
nmol/l
16.1
17.3
0.19
12
70
(3017569) Oxygen content in Arterial blood
12
79
1.52
0.62
2.2
2.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
410
4322
0.93
0.62
3.4
3.3
mg/l
986.1
275.1
1.31
268
2763
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
176
0.68
0.62
1.1
1.7
%
77.0
63.9
—
6
118
(4094501)
28
357
0.78
0.61
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1156
11344
1.08
0.61
4.6
4.7
mu/l
4.4
2.1
0.47
1040
10170
(3036603) Volume of Urine
13
88
1.48
0.60
1.5
1.5
ml
1726.8
1768.0
—
6
20
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
108
1210
0.88
0.59
1.9
1.8
%
1.6
1.6
0.19
85
1013
(3001019) Free T4 and TSH panel - Serum or Plasma
27
343
0.78
0.58
1.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
298
0.77
0.58
1.3
1.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
42
346
1.22
0.58
4.1
3.3
mmol/l
1.6
1.6
0.05
42
337
(3011288) Drugs identified in Urine by Screen method
15
106
1.42
0.57
1.0
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
229
0.74
0.56
1.8
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
90
1.45
0.55
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
15
107
1.41
0.55
1.1
1.4
—
32.3
—
0
7
(3047189) Immunofixation for 24 hour Urine
11
74
1.49
0.53
1.7
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
424
1.19
0.52
1.7
1.5
ug/g
205.1
281.1
2.26
31
256
(3000475) Leukocytes [#/volume] in Synovial fluid
28
348
0.80
0.52
2.0
1.7
e6/l
15017.8
16708.3
0.15
19
254
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(4015189)
7
45
1.56
0.49
1.0
2.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
155
0.71
0.48
2.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
318
1.20
0.47
4.5
3.6
mg/l
26.5
28.1
0.13
26
208
(3000330) Specific gravity of Urine by Test strip
83
742
1.13
0.45
3.6
3.9
—
—
—
0
0
(4024509)
17
130
1.31
0.44
1.2
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
262
0.80
0.42
1.4
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
33
1.52
0.41
1.0
1.6
g/l
23.4
28.9
—
5
26
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
865.1
—
0
6
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
47.3
—
0
17
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
60
1.34
0.40
1.0
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
88
1.37
0.40
1.3
1.6
umol/l
20.1
14.5
1.71
12
82
(3009015) Lactate [Moles/volume] in Synovial fluid
0
18
0.00
0.40
0.0
1.3
—
7.1
—
0
10
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
409
1.15
0.39
1.6
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
35
1.43
0.39
2.6
3.0
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
1.5
—
0
13
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
181
1915
0.94
0.33
1.2
1.3
iu/ml
60.4
37.3
0.53
59
609
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
312
1.16
0.33
1.8
1.7
nmol/l
52.4
42.0
1.30
36
297
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
185
1.19
0.29
1.0
1.1
g/l
1.8
1.6
1.02
22
165
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
804
0.92
0.28
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
76
1.32
0.28
2.0
1.5
g/l
1.0
1.0
—
10
76
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
11
85
1.30
0.28
1.2
1.4
u/l
30.8
30.1
0.03
11
66
(3000492) Spirometry study
116
1090
1.07
0.27
1.6
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
150
1.20
0.26
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
67
1.20
0.26
1.6
1.1
nmol/l
112.8
150.2
—
8
67
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
77
1.17
0.24
1.3
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
91
852
1.07
0.24
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(4034850)
44
401
1.10
0.21
10.7
11.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
14.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
26.8
—
0
14
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
365
1.10
0.19
2.0
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
441
4499
0.97
0.18
4.0
4.6
%
22.4
21.4
0.66
225
2310
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
368
1.09
0.17
3.2
2.3
ug/min
153.5
99.5
0.33
23
219
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(44813793)
5
68
0.73
0.17
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
152
0.85
0.17
1.1
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
247
2404
1.03
0.16
1.2
1.2
u/ml
2.0
1.6
0.16
54
611
(3020961) Endomysium IgA Ab [Titer] in Serum
51
476
1.07
0.16
1.1
1.1
titre
—
197.1
—
0
10
(3022621) pH of Urine by Test strip
84
883
0.95
0.16
3.5
3.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
151
0.86
0.15
1.1
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
245
1.10
0.15
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
316
3228
0.97
0.15
2.7
3.2
ug/l
0.8
0.8
0.33
220
2249
(3009508) Creatinine [Moles/volume] in Urine
434
4414
0.98
0.15
3.2
3.2
mmol/l
7.1
7.4
1.02
360
3643
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
170
0.88
0.13
1.5
1.3
nmol/l
0.8
0.7
0.21
15
160
(4281824)
15
133
1.13
0.12
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
114
1.14
0.11
2.7
1.9
u/field
1.4
2.5
—
5
43
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
157
0.89
0.11
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
157
0.89
0.11
1.1
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
28
301
0.93
0.11
1.5
1.2
u/ml
2.5
6.4
—
5
44
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
171
1749
0.97
0.10
4.2
4.7
%
31.9
32.9
0.49
126
1131
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
634
0.96
0.09
1.2
1.2
iu/ml
157.3
139.3
0.10
23
229
(3003338) MCHC [Mass/volume]
1004
9993
1.01
0.08
50.1
21.7
g/l
331.3
332.0
1.81
994
9912
(4211845)
5
64
0.78
0.08
3.2
2.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
76
1.05
0.07
1.8
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
28
296
0.94
0.07
1.5
1.2
u/ml
1.5
3.8
—
5
30
(3008898) HLA-B27 [Presence]
31
294
1.06
0.07
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
80
0.87
0.07
2.1
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
158
1.08
0.06
1.7
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
23
218
1.06
0.05
2.1
1.7
mu/l
377.9
288.0
0.67
23
200
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
16
150
1.07
0.04
1.2
1.3
pmol/l
200.9
273.4
0.75
11
119
(3014051) Protein [Presence] in Urine by Test strip
31
322
0.96
0.04
2.1
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
92
1.09
0.03
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
147
0.95
0.01
1.5
1.3
nmol/l
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
126
1.03
0.00
1.1
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
128
1.02
0.00
1.4
1.4
%
12.5
28.5
—
8
83
(3000764) Benzodiazepines [Presence] in Urine
16
158
1.01
0.00
1.1
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1236
12363
1.00
0.00
5.1
5.0
mmol/l
6.0
6.1
0.20
1116
11063
(40768793) Breast Pathology biopsy report
26
255
1.02
0.00
1.3
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
10
105
0.95
0.00
1.0
1.0
ng/l
44.2
45.0
—
5
59
(3011648) Oxygen content in Venous blood
13
125
1.04
0.00
21.4
2.8
%
11.9
10.9
0.32
13
125
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
81
0.99
0.00
1.0
1.4
promille
1.2
1.0
—
8
66
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
79
0.89
0.00
1.6
1.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
335.2
—
0
6
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
59
0.85
0.00
3.2
2.9
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
160
1.00
0.00
1.1
1.9
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
160
1.00
0.00
1.1
1.9
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(3011048) Pyruvate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
94.9
—
0
7
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
82
0.98
0.00
1.0
2.5
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_DLBCL – Diffuse large B-cell lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).